Analysis of Related Risk Factors of Hypoglycemia Consciousness Disorder

February 5, 2023 updated by: Chongqing Renji Hospital, University of Chinese Academy of Sciences
Objective to explore the high risk factors and inducements of consciousness disorder in patients with hypoglycemia, and to conduct a retrospective study.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Observational

Enrollment (Actual)

292

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • China
    • Chongqing
      • Chongqing, Chongqing, China, 400062
        • Chongqing Renji Hospital, University of Chinese Academy of Sciences

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 80 years (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

N/A

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

Through retrospective control study, this study analyzed the high-risk factors and predisposing factors of hypoglycemia patients, laid a certain foundation for improving the diagnosis and treatment level of hypoglycemia consciousness disorder, and provided a certain scientific basis for further exploring the mechanism of hypoglycemia consciousness disorder

Description

Inclusion Criteria:

Symptoms of hypoglycemia such as palpitation, sweating and fatigue were found at the time of treatment. At the same time, the blood glucose of non-diabetic patients was less than 2.8mmol/L, and the blood glucose of diabetic patients was less than 3.9mmol/L

Exclusion Criteria:

Exclusion criteria: Although there were hypoglycemia symptoms at the time of treatment, the blood glucose of non-diabetic patients was more than 2.8mmol/L, and the blood glucose of diabetic patients was more than 3.9mmol/L.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Hypoglycemic disturbance group
Other: Observation and follow-up
Observation and follow-up study
Hypoglycemia was not a disorder of consciousness group
Other: Observation and follow-up
Observation and follow-up study

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Analysis of risk factors of hypoglycemia with disturbance of consciousness
Time Frame: 2021-2011
Analysis of risk factors of hypoglycemia with disturbance of consciousness
2021-2011

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Chongqing Renji Hospital, University of Chinese Academy of Sciences

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

July 25, 2021

Primary Completion (ACTUAL)

February 20, 2022

Study Completion (ACTUAL)

January 15, 2023

Study Registration Dates

First Submitted

June 23, 2021

First Submitted That Met QC Criteria

July 18, 2021

First Posted (ACTUAL)

July 21, 2021

Study Record Updates

Last Update Posted (ACTUAL)

February 8, 2023

Last Update Submitted That Met QC Criteria

February 5, 2023

Last Verified

June 1, 2021

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 31921003

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe